{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:30:32Z","timestamp":1790767832932,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1012,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/ajt.15583","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T03:33:07Z","timestamp":1566790387000},"page":"600-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5551-4234","authenticated-orcid":false,"given":"Nikhil","family":"Kapila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawtar","family":"Al-Khalloufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Bejarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Vanatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xaralambos B.","family":"Zervos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.15583_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(92)90138-F","article-title":"Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications","volume":"14","author":"O\u2019Grady","year":"1992","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.15583_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis","volume":"13","author":"Davies","year":"1991","journal-title":"Hepatology."},{"key":"10.1111\/ajt.15583_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/lt.23559","article-title":"Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis","volume":"19","author":"Verna","year":"2013","journal-title":"Liver Transpl."},{"key":"10.1111\/ajt.15583_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1681\/ASN.V961109","article-title":"Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients","volume":"9","author":"MunozDeBustillo","year":"1998","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15583_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/lt.500050417","article-title":"Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection","volume":"5","author":"Delladetsima","year":"1999","journal-title":"Liver Transpl Surg."},{"key":"10.1111\/ajt.15583_bib6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1600-6143.2011.03608.x","article-title":"Fibrosing cholestatic hepatitis in HIV\/HCV co-infected transplant patients-usefulness of early markers after liver transplantation","volume":"11","author":"Antonini","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15583_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0016-5085(94)95829-7","article-title":"Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection","volume":"106","author":"Lim","year":"1994","journal-title":"Gastroenterology."},{"key":"10.1111\/ajt.15583_bib8","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15583_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of Hepatitis C-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med."},{"key":"10.1111\/ajt.15583_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: An open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med."},{"key":"10.1111\/ajt.15583_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donor for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15583_bib12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/ajt.15311","article-title":"Transplanting hepatitis C virus-infected hearts into uninfected recipients: a single-arm trial","volume":"19","author":"McClean","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15583_bib13","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.15583_bib14","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.15162","article-title":"Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors","volume":"19","author":"Kwong","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15583_bib15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/lt.22175","article-title":"Post\u2013liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria","volume":"16","author":"Narang","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1111\/ajt.15583_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2012.04.022","article-title":"Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFN\u03b1-2a plus ribavirin","volume":"57","author":"Calmus","year":"2012","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.15583_bib17","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.cgh.2015.05.030","article-title":"Efficacy of sofosbuvir and dacltasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation","volume":"13","author":"Leroy","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1111\/ajt.15583_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2011.06.031","article-title":"Immunosuppression and HCV recurrence after liver transplantation","volume":"56","author":"Samonakis","year":"2012","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.15583_bib19","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1007\/s10620-010-1149-x","article-title":"Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation","volume":"55","author":"Schmitt","year":"2010","journal-title":"Dig Dis Sci."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15583","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15583","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352222214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352222214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:41Z","timestamp":1761629141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352222214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S160061352222214X"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15583","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}